Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.25) by 8 percent. This is a 3.85 percent decrease over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $21.688 million which beat the analyst consensus estimate of $20.400 million by 6.31 percent. This is a 21.99 percent increase over sales of $17.779 million the same period last year.